Tamil Nadu: 12th Mega COVID Vaccination Camp Held

In Tamil Nadu, the 12th mega COVID-19 vaccination camp was conducted amid heavy rain in several districts. According to officials, people were vaccinated at 50,000 camps across the state.

A total of 1,600 camps were put up in Greater Chennai Corporation to inoculate people.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

‘Ma Subramanian said his state is nearing the national average on Covid-19 vaccination, adding about 78 lakh people are due to take the second dose of the vaccine.’

Tweet it Now

Tamil Nadu Health Minister Ma Subramanian told IANS: "This has been made possible due to the inspirational leadership of our Chief Minister (MK Stalin) as well as the undying spirit of health department professionals."

Talking on the threat posed by the new Omicron variant of the Covid, he said that travellers from South Africa reaching the state will have to undergo quarantine for eight days.

The Minister also said Covid-19 vaccination is must for those visiting public places including those who visit Tamil Nadu State Marketing Corporation liquor shops.

US CDC Approves Pfizer COVID-19 Vaccine for Kids Aged 5-11
The US Centers for Disease Control and Prevention (CDC) has recommended Pfizer COVID-19 vaccine for children aged 5-11 years.

He inspected the mega vaccination camp at Adayar along with Higher Education Minister K. Ponmudi, and said that 77.3 per cent of the population have been vaccinated with the first dose while the second dose coverage was 42.10 per cent.

The Minister also said that travellers from South Africa, China, Botswana, Hong Kong, Brazil, and Italy will be tested at the Chennai international airport to keep a check on the Omicron threats.

COVID-19 Vaccine Boosters Authorized for All Adults
The United States Centers for Disease Control and Prevention (CDC) endorsed booster doses of Pfizer/BioNTech's and Moderna's Covid-19 vaccines for all US adults.

Source-IANS

New Report Suggests the BBV152 COVID-19 Vaccine is Safe and Protective
Interim analysis from phase 3 randomized controlled trial conducted in India between November 2020 and May 2021 of 24,419 participants aged 18-97 years in India reported that efficacy after two weeks of two doses of BBV152 is 77.8% against symptomatic COVID-19 infection.